CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

A new study has examined the effects of GLP-1 drugs on 175 different health outcomes. ​​​While these drugs have been found to ...

Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.

Because poor adherence to GLP-1 receptor agonists may limit the long ... Wegovy), or tirzepatide (Mounjaro, Zepbound) -- all of which hold indications for type 2 diabetes and chronic weight ...

Josh Gad is opening up about the weight loss success he’s had with GLP-1 medication — and sharing some of the conflicted ...

Similarly, Zepbound is Mounjaro’s weight-loss counterpart ... said many of his patients report life-changing weight loss while on GLP-1 medications. “I have some veterans who have lost ...